Statin Treatment in Children With Familial Hypercholesterolemia
Top Cited Papers
Open Access
- 7 August 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 116 (6) , 664-668
- https://doi.org/10.1161/circulationaha.106.671016
Abstract
Background— We previously demonstrated in a randomized placebo-controlled trial that 2-year pravastatin treatment induced a significant regression of carotid intima-media thickness (IMT) in 8- to 18-year-old children with familial hypercholesterolemia. Subsequently, we continued to follow up these children to explore the relation between the age of statin initiation and carotid IMT after follow-up on statin treatment. We also examined safety aspects of statin therapy during this long-term follow-up. Methods and Results— All 214 children who initially participated in the previous placebo-controlled study were eligible for the follow-up study. After completion of the placebo-controlled study, all children continued treatment with pravastatin 20 or 40 mg, depending on their age. Blood samples were taken on a regular basis for lipids and safety parameters, and a carotid IMT measurement was performed after an average treatment period of 4.5 years. Follow-up data for 186 children were available for the statistical analyses. Multivariate analyses revealed that age at statin initiation was an independent predictor for carotid IMT after follow-up with adjustment for carotid IMT at initiation of statin treatment, sex, and duration of treatment. Early initiation of statin treatment was associated with a subsequently smaller IMT. Furthermore, no serious laboratory adverse events were reported during follow-up, and statin treatment had no untoward effects on sexual maturation. Conclusions— These data indicate that early initiation of statin treatment delays the progression of carotid IMT in adolescents and young adults. The present study shows for the first time that early initiation of statin therapy in children with familial hypercholesterolemia might be beneficial in the prevention of atherosclerosis in adolescence.Keywords
This publication has 13 references indexed in Scilit:
- Efficacy and Safety of Lovastatin Therapy in Adolescent Girls With Heterozygous Familial HypercholesterolemiaPediatrics, 2005
- Efficacy and Safety of Statin Therapy in Children With Familial HypercholesterolemiaJAMA, 2004
- Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trialThe Journal of Pediatrics, 2003
- Efficacy and Safety of Statin Therapy in Children With Familial HypercholesterolemiaCirculation, 2002
- Efficacy and Safety of Lovastatin in Adolescent Males With Heterozygous Familial HypercholesterolemiaJAMA, 1999
- Short-Term Efficacy and Safety of Pravastatin in 72 Children with Familial HypercholesterolemiaPediatric Research, 1996
- Detection of silent coronary artery disease in adolescents and young adults with familial hypercholesterolemia by single-photon emission computed tomography thallium-201 scanningThe American Journal of Cardiology, 1992
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992
- Relationship of Atherosclerosis in Young Men to Serum Lipoprotein Cholesterol Concentrations and SmokingJAMA, 1990
- Familial Hypercholesterolemia (One Form of Familial Type II Hyperlipoproteinemia) A STUDY OF ITS BIOCHEMICAL, GENETIC, AND CLINICAL PRESENTATION IN CHILDHOODJournal of Clinical Investigation, 1974